SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0000950103-09-000639
Filing Date
2009-03-26
Accepted
2009-03-26 14:35:49
Documents
6
Group Members
GENENTECH, INC.ROCHE HOLDING LTD

Document Format Files

Seq Description Document Type Size
1 SC TO T AMENDMENT NO. 9 dp12955_sctota9.htm SC TO-T/A 196218
2 MEDIA RELEASE dp12955_ex-a5lxiii.htm EX-99.A.5.LXIII 17685
3 GRAPHIC roche.jpg GRAPHIC 2921
4 MEDIA RELEASE dp12955_ex-a5lxiv.htm EX-99.A.5.LXIV 15228
5 GRAPHIC genentech.jpg GRAPHIC 9193
6 GRAPHIC roche2.jpg GRAPHIC 2988
  Complete submission text file 0000950103-09-000639.txt   252955
Mailing Address 1 DNA WAY . SOUTH SAN FRANCISCO CA 94080
Business Address 1 DNA WAY SOUTH SAN FRANCISCO CA 94080 650-225-1000
GENENTECH INC (Subject) CIK: 0000318771 (see all company filings)

IRS No.: 942347624 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13E3/A | Act: 34 | File No.: 005-32488 | Film No.: 09706327
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 DNA WAY . SOUTH SAN FRANCISCO CA 94080
Business Address 1 DNA WAY SOUTH SAN FRANCISCO CA 94080 650-225-1000
GENENTECH INC (Subject) CIK: 0000318771 (see all company filings)

IRS No.: 942347624 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-32488 | Film No.: 09706328
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1220 N. MARKET STREET SUITE 334 WILMINGTON DE 19801
Business Address 1220 N. MARKET STREET SUITE 334 WILMINGTON DE 19801 302-425-0151
Roche Investments USA Inc. (Filed by) CIK: 0001454654 (see all company filings)

IRS No.: 264088160 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A